Literature DB >> 24092238

MyoD is a tumor suppressor gene in medulloblastoma.

Joyoti Dey1, Adrian M Dubuc, Kyle D Pedro, Derek Thirstrup, Brig Mecham, Paul A Northcott, Xiaochong Wu, David Shih, Stephen J Tapscott, Michael LeBlanc, Michael D Taylor, James M Olson.   

Abstract

While medulloblastoma, a pediatric tumor of the cerebellum, is characterized by aberrations in developmental pathways, the majority of genetic determinants remain unknown. An unbiased Sleeping Beauty transposon screen revealed MyoD as a putative medulloblastoma tumor suppressor. This was unexpected, as MyoD is a muscle differentiation factor and not previously known to be expressed in cerebellum or medulloblastoma. In response to deletion of one allele of MyoD, two other Sonic hedgehog-driven mouse medulloblastoma models showed accelerated tumor formation and death, confirming MyoD as a tumor suppressor in these models. In normal cerebellum, MyoD was expressed in the proliferating granule neuron progenitors that are thought to be precursors to medulloblastoma. Similar to some other tumor suppressors that are induced in cancer, MyoD was expressed in proliferating medulloblastoma cells in three mouse models and in human medulloblastoma cases. This suggests that although expression of MyoD in a proliferating tumor is insufficient to prevent tumor progression, its expression in the cerebellum hinders medulloblastoma genesis. ©2013 AACR

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24092238      PMCID: PMC4014678          DOI: 10.1158/0008-5472.CAN-13-0730-T

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  49 in total

1.  Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development.

Authors:  M A Rudnicki; T Braun; S Hinuma; R Jaenisch
Journal:  Cell       Date:  1992-10-30       Impact factor: 41.582

2.  MyoD induces growth arrest independent of differentiation in normal and transformed cells.

Authors:  M Crescenzi; T P Fleming; A B Lassar; H Weintraub; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

3.  De novo methylation of the MyoD1 CpG island during the establishment of immortal cell lines.

Authors:  P A Jones; M J Wolkowicz; W M Rideout; F A Gonzales; C M Marziasz; G A Coetzee; S J Tapscott
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

4.  Cell proliferation inhibited by MyoD1 independently of myogenic differentiation.

Authors:  V Sorrentino; R Pepperkok; R L Davis; W Ansorge; L Philipson
Journal:  Nature       Date:  1990-06-28       Impact factor: 49.962

5.  Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts.

Authors:  D Lyden; A Z Young; D Zagzag; W Yan; W Gerald; R O'Reilly; B L Bader; R O Hynes; Y Zhuang; K Manova; R Benezra
Journal:  Nature       Date:  1999-10-14       Impact factor: 49.962

6.  Progressive increases in the methylation status and heterochromatinization of the myoD CpG island during oncogenic transformation.

Authors:  W M Rideout; P Eversole-Cire; C H Spruck; C M Hustad; G A Coetzee; F A Gonzales; P A Jones
Journal:  Mol Cell Biol       Date:  1994-09       Impact factor: 4.272

7.  OTX2 represses myogenic and neuronal differentiation in medulloblastoma cells.

Authors:  Ren-Yuan Bai; Verena Staedtke; Hart G Lidov; Charles G Eberhart; Gregory J Riggins
Journal:  Cancer Res       Date:  2012-09-17       Impact factor: 12.701

8.  Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples.

Authors:  Paul A Northcott; David J H Shih; Marc Remke; Yoon-Jae Cho; Marcel Kool; Cynthia Hawkins; Charles G Eberhart; Adrian Dubuc; Toumy Guettouche; Yoslayma Cardentey; Eric Bouffet; Scott L Pomeroy; Marco Marra; David Malkin; James T Rutka; Andrey Korshunov; Stefan Pfister; Michael D Taylor
Journal:  Acta Neuropathol       Date:  2011-11-06       Impact factor: 17.088

9.  nuID: a universal naming scheme of oligonucleotides for illumina, affymetrix, and other microarrays.

Authors:  Pan Du; Warren A Kibbe; Simon M Lin
Journal:  Biol Direct       Date:  2007-05-31       Impact factor: 4.540

10.  The muscle regulatory factors MyoD and myf-5 undergo distinct cell cycle-specific expression in muscle cells.

Authors:  M Kitzmann; G Carnac; M Vandromme; M Primig; N J Lamb; A Fernandez
Journal:  J Cell Biol       Date:  1998-09-21       Impact factor: 10.539

View more
  13 in total

Review 1.  Genetic and molecular alterations across medulloblastoma subgroups.

Authors:  Patryk Skowron; Vijay Ramaswamy; Michael D Taylor
Journal:  J Mol Med (Berl)       Date:  2015-09-09       Impact factor: 4.599

2.  MiR-206, a Cerebellum Enriched miRNA Is Downregulated in All Medulloblastoma Subgroups and Its Overexpression Is Necessary for Growth Inhibition of Medulloblastoma Cells.

Authors:  Pooja Panwalkar; Aliasgar Moiyadi; Atul Goel; Prakash Shetty; Naina Goel; Epari Sridhar; Neelam Shirsat
Journal:  J Mol Neurosci       Date:  2015-04-10       Impact factor: 3.444

Review 3.  Sleeping Beauty transposon system for genetic etiological research and gene therapy of cancers.

Authors:  Xiaomei Hou; Yan Du; Yang Deng; Jianfeng Wu; Guangwen Cao
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

4.  Efficient derivation and inducible differentiation of expandable skeletal myogenic cells from human ES and patient-specific iPS cells.

Authors:  Sara M Maffioletti; Mattia F M Gerli; Martina Ragazzi; Sumitava Dastidar; Sara Benedetti; Mariana Loperfido; Thierry VandenDriessche; Marinee K Chuah; Francesco Saverio Tedesco
Journal:  Nat Protoc       Date:  2015-06-04       Impact factor: 13.491

Review 5.  Generation of skeletal muscle cells from pluripotent stem cells: advances and challenges.

Authors:  Ramzey Abujarour; Bahram Valamehr
Journal:  Front Cell Dev Biol       Date:  2015-05-13

6.  Insights into the Transcriptional Architecture of Behavioral Plasticity in the Honey Bee Apis mellifera.

Authors:  Abdullah M Khamis; Adam R Hamilton; Yulia A Medvedeva; Tanvir Alam; Intikhab Alam; Magbubah Essack; Boris Umylny; Boris R Jankovic; Nicholas L Naeger; Makoto Suzuki; Matthias Harbers; Gene E Robinson; Vladimir B Bajic
Journal:  Sci Rep       Date:  2015-06-15       Impact factor: 4.379

7.  Identification of MyoD-Responsive Transcripts Reveals a Novel Long Non-coding RNA (lncRNA-AK143003) that Negatively Regulates Myoblast Differentiation.

Authors:  Yiwen Guo; Jingnan Wang; Mingfei Zhu; Rui Zeng; Zaiyan Xu; Guoliang Li; Bo Zuo
Journal:  Sci Rep       Date:  2017-06-06       Impact factor: 4.379

8.  Inhibitory effect of MyoD on the proliferation of breast cancer cells.

Authors:  Changjing Cai; Xiaoqun Qin; Ziyi Wu; Qixia Shen; Wenqian Yang; Shujun Zhang; Jinling Duan; Fenglan Liang; Chi Liu
Journal:  Oncol Lett       Date:  2016-04-18       Impact factor: 2.967

9.  Convergence of BMI1 and CHD7 on ERK Signaling in Medulloblastoma.

Authors:  Sara Badodi; Adrian Dubuc; Xinyu Zhang; Gabriel Rosser; Mariane Da Cunha Jaeger; Michelle M Kameda-Smith; Anca Sorana Morrissy; Paul Guilhamon; Philipp Suetterlin; Xiao-Nan Li; Loredana Guglielmi; Ashirwad Merve; Hamza Farooq; Mathieu Lupien; Sheila K Singh; M Albert Basson; Michael D Taylor; Silvia Marino
Journal:  Cell Rep       Date:  2017-12-05       Impact factor: 9.423

Review 10.  The untold stories of the speech gene, the FOXP2 cancer gene.

Authors:  Maria Jesus Herrero; Yorick Gitton
Journal:  Genes Cancer       Date:  2018-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.